| Mass | 20MG |
|---|
Secretagogue Research
CJC-1295 + ipa Spray
Lot report pending · Lab report library
MASS
QUANTITY
1
$145.99
BUY ONE, GET ONE FREE · APPLIED IN YOUR CART
Order within — · ships today
Arrives Nov 11 – Nov 13 · free 2-day shipping over $150
Third Party
Tested & Verified
Secure Checkout
SSL Encrypted
Secure payments via
$145.99
Availability: In stock (can be backordered)
CHEMICAL BLOCK
The data your lab notebook needs.
Identity data for this material. Published lot reports, where one exists, are in the lab report library.
| FORM | Lyophilized Powder |
|---|---|
| PURITY | Per lot (see published lab report) |
| STORAGE | Lyophilized (powder): −20°C, away from light, unopened |
COMMON QUESTIONS
Everything researchers ask before ordering.
Compound information
CJC-1295 (no DAC) + Ipamorelin research data.
Two-component blend: modified GRF(1-29) amide (CJC-1295 without DAC) and ipamorelin
This product is a blend of two separate synthetic peptides. The first is CJC-1295 without DAC, also called modified GRF(1-29): a 29-residue peptide amide based on the 1-29 GHRH sequence with four substitutions (D-Ala2, Gln8, Ala15, Leu27). It is a different molecule from CJC-1295 with DAC, which adds a C-terminal lysine carrying a maleimidopropionyl group. The second component is ipamorelin, the pentapeptide amide Aib-His-D-2Nal-D-Phe-Lys-NH2.
Published work on both components is largely analytical chemistry: liquid chromatography-mass spectrometry and antibody-based purification methods that list CJC-1295 and ipamorelin among their target peptides and report detection limits, extraction yield and precision. The name CJC-1295 is used in the literature for both the DAC and no-DAC forms, so a paper's sequence or mass should be checked before it is read as describing this molecule. No blend-level data are cited here.
| Type | Two-component synthetic peptide blend |
|---|---|
| Also listed as | CJC 1295 ipamorelin, CJC-1295 no DAC, mod GRF (1-29) |
| Components | 2 |
| Total peptide mass | 20 mg |
| PubChem CID | 56841945 (CJC-1295 no DAC) · 9831659 (ipamorelin) |
| Component | Identity |
|---|---|
| CJC-1295 without DAC (modified GRF(1-29)) | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 · C152H252N44O42 · ~3367.9 g/mol · CAS 863288-34-0 |
| Ipamorelin | Aib-His-D-2Nal-D-Phe-Lys-NH2 · C38H49N9O5 · ~711.9 g/mol · CAS 170851-70-4 |
Lab reports
Lot reports for this product.
Each report names the lab, the lot, the test date and every assay run. Verify it on the lab's own portal.
No lot report is published for this product yet. Reports are added to the lab report library as testing completes.
Sources & references
Published literature.
Peer-reviewed papers on CJC-1295 (no DAC) + Ipamorelin, linked to PubMed.
- Solid-phase extraction of small biologically active peptides on cartridges and microelution 96-well plates from human urine.
Semenistaya E, Zvereva I, Krotov G, et al.. Drug Test Anal (2016). PubMed 26472487 → - Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography-mass spectrometry.
Kwok WH, Ho EN, Lau MY, et al.. Anal Bioanal Chem (2013). PubMed 23318763 →
For in-vitro laboratory research use only by qualified researchers. Not for human or veterinary consumption. Not a drug, dietary supplement or cosmetic. These statements have not been evaluated by the FDA, and this product is not intended to diagnose, treat, cure or prevent any disease. This site does not provide medical advice. Literature listed above describes published research and is not a claim about this product. By purchasing, the buyer confirms the material is for laboratory research conducted by qualified personnel.
